- Home
- STEP vs VCYT Comparison
STEP vs VCYT Comparison
Compare STEP & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STEP | VCYT |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | STEP | VCYT |
|---|---|---|
| Price | $45.20 | $53.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $71.00 | $44.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.35 |
| Revenue | ★ $1,993,603,000.00 | N/A |
| Revenue This Year | N/A | $13.76 |
| Revenue Next Year | $26.41 | $12.35 |
| P/E Ratio | ★ N/A | $150.34 |
| Revenue Growth | ★ 69.69 | N/A |
| 52 Week Low | $40.58 | $22.61 |
| 52 Week High | $77.80 | $53.70 |
Technical Indicators
Market Signals| Indicator | STEP | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 42.68 | 73.18 |
| Support Level | $44.48 | $40.27 |
| Resistance Level | $49.03 | N/A |
| Average True Range (ATR) | 2.50 | 2.44 |
| MACD | 0.20 | 0.07 |
| Stochastic Oscillator | 40.51 | 97.97 |
Price Performance
Historical ComparisonAbout STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).